Literature DB >> 3855291

Continuous positive airway pressure: a breathing system to minimize respiratory work.

D R Hillman, K E Finucane.   

Abstract

During continuous positive airway pressure (CPAP) the work of breathing is least when there is no change of airway pressure measured at the mouth (delta Paw) during respiration. In this study we consider the physical properties of CPAP circuits which determine the magnitude of delta Paw, and apply this information to the design of a simple, reliable CPAP system that minimizes delta Paw and incorporates the additional advantages of low-flow rates and the use of commonly available proven components. Using a weighted reservoir bag and threshold CPAP valve to maintain pressure, we found that delta Paw may be reduced to less than 1.0 cm H2O during quiet breathing, at a tidal volume of 700 ml and maximum inspiratory flow of 1.35 L/sec. delta Paw was dependent on both the resistance and the reactance of the circuit components; it was increased when resistance or flow rates were high, and when delivery pressure depended on the elastic tension in the wall of the reservoir bag or on compression of the bag with springs or elastic bands.

Entities:  

Mesh:

Year:  1985        PMID: 3855291     DOI: 10.1097/00003246-198501000-00010

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Inspiratory work imposed by continuous positive airway pressure (CPAP) machines: the effect of CPAP level and endotracheal tube size.

Authors:  J L Moran; S Homan; M O'Fathartaigh; M Jackson; P Leppard
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Total inspiratory work with modern demand valve devices compared to continuous flow CPAP.

Authors:  L F Samodelov; K J Falke
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  A high flow turbine CPAP system.

Authors:  J L Moran; M P Jackson; D M Cameron; A R Peisach; D N Cunningham; M S O'Fathartaigh
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.